These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #PathArticles pages here: https://serdarbalci.netlify.com/categories/PathArticles/ or here: https://serdarbalci.wordpress.com/?s=PathArticles/ See selected social media based textbook project here: http://www.patolojinotlari.com/
Congrats @sloan_kettering Patient & Family Advisory Council for Quality (PFACQ) on @nejmcatalyst article: https://t.co/uHVs1qpI4Y #quality
— Samson W. Fine, MD (@rovingatuscap) December 7, 2016
pathology report should ideally be a clinical (meaning actionable), rather than research document
— Samson W. Fine, MD (@rovingatuscap) October 20, 2016
I agree 3+3, but if I got an outside review where it was called 3+4 I may not disagree. In our practice tiny 3+4 often surveilled and re-biopsied often after MRI. But if it is a "real" 3+4, it will typically declare with good follow up. Default to lower if not definitive, IMHO.
— Matthew Wasco (@Gleason4plus5) April 11, 2019
Mucinous Tubular and Spindle Cell Carcinoma: A Review of Histopathology and Clinical and Prognostic Implications; read this @ArchivesPath from @ManipalUni
— CAPathologists (@Pathologists) January 29, 2020
resident #pathologists Shrinidhi Nathany, MBBS; Vidya Monappa, MBBS, MD: https://t.co/rV9mEWMqZR. pic.twitter.com/HdJJ3Qir7K
Mucinous Tubular and Spindle Cell Carcinoma: A Review of Histopathology and Clinical and Prognostic Implications; read this @ArchivesPath from @ManipalUni
— CAPathologists (@Pathologists) January 28, 2020
resident #pathologists Shrinidhi Nathany, MBBS; Vidya Monappa, MBBS, MD: https://t.co/rV9mEWMqZR. pic.twitter.com/3PY5m4Pi4S
Mucinous Tubular and Spindle Cell Carcinoma: A Review of Histopathology and Clinical and Prognostic Implications; read this @ArchivesPath from @ManipalUni
— CAPathologists (@Pathologists) January 27, 2020
resident #pathologists Shrinidhi Nathany, MBBS; Vidya Monappa, MBBS, MD: https://t.co/rV9mEWMqZR. pic.twitter.com/xKibwLPfu9
The recent guidelines from the @US_FDA provide a much-needed push toward remote work for digital pathologists everywhere. https://t.co/B2GFGoylTR
— Corista (@Corista_LLC) May 13, 2020
#FDA encourages remote review of #digitalpathology slides amid #COVID19 https://t.co/GZgvXULEGD #pathology #pathologists #histology #covidusa #COVID19US #CoronavirusUSA #CLIA
— Greg Slabodkin (@Slabodkin) April 27, 2020
Nerve Renew Review: New Shocking Facts Revealed https://t.co/lBw3FXuwU2
— Robert Z. Orlowski (@Myeloma_Doc) April 25, 2020
Keep up with the latest articles from JNCI. Sign up for new issue alerts from the journal: https://t.co/duT8SrhjeE pic.twitter.com/dEt3fMfmhv
— JNCI (@JNCI_Now) April 15, 2020
Written by @RichardG_AR, @kamrannaim and @RaymCrow. Published in @LearnedPublish from @alpsp. https://t.co/zdf7mOKwYy
— Annual Reviews (@AnnualReviews) April 15, 2020
New Research: Editorial: The Silent Cry: How to Turn Translational Medicine Towards Patients and Unmet Medical Needs https://t.co/PDKhQF5ECK #medicalcare #clinical #pathology
— Frontiers Medicine (@FrontMedicine) March 21, 2020
Join me for the next High Yield #pulmpath slide review session.
— Matthew Cecchini (@Path_Matt) March 21, 2020
This time it will be non-neoplastic lung.
Join the Zoom Meeting at;https://t.co/AJFucerj9V
Meeting ID: 937 919 4310
I have scheduled it at 9:00 am CST so that our global #pathology colleagues can hopefully join pic.twitter.com/KfTJtW5VvB
A dozen national science advisers ask publishers to make all coronavirus research available for AI https://t.co/QAOg5eeBxt by @b0yle
— Oren Etzioni (@etzioni) March 13, 2020
New2Trip: Deprescribing for Older Veterans: Systematic Review https://t.co/UKArtRyHVg
— Trip Database (@tripdatabase) March 12, 2020
MUST-READ article for any Python developer working with text data. I should have read it earlier. https://t.co/09wS6Bshlq
— Alex Combessie (@alex_combessie) March 12, 2020
Why Some COVID-19 Cases Are Worse than Others #science #research https://t.co/7pocAhs1rO
— Antibody Resource (@absresourcepage) March 3, 2020
First-ever Pathology of Early-phase Lung Infection With the 2019 Coronavirus Published | Technology Networks https://t.co/S0PzofonbE
— Susan A (@Yiayia_sue) February 28, 2020
There is a high prevalence of tendon pathology in an
— Benoy Mathew (@function2fitnes) December 21, 2019
asymptomatic male runners with no history of Achilles tendon pain (around 46% in this study)
Further research is needed, to determine if these changes are transient, irreversible or predictive of future symptom development. pic.twitter.com/lt4HZ4vpej
These tweets are selected automatically with #rstats code. Please inform me if any is inappropriate. See other #PathArticles pages here: https://serdarbalci.netlify.com/categories/PathArticles/ or here: https://serdarbalci.wordpress.com/?s=PathArticles/ See selected social media based textbook project here: http://www.patolojinotlari.com/
)